查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1826808

2025年全球近視治療市場報告

Myopia Treatment Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，近視治療市場規模強勁成長，從2024年的178.2億美元增加至2025年的195.2億美元，複合年成長率達9.6%。這段時期的成長可歸因於老年人口的成長、政府宣傳計畫的加強、近視治療意識的增強、研發投入的增加以及遠視視力障礙發病率的上升。

預計未來幾年近視治療市場規模將強勁成長，到2029年將達到279億美元，複合年成長率為9.3%。預測期內的成長歸因於遠視力障礙發病率的上升、數位管道使用率的提高、醫療基礎設施的完善、近視發病率的上升以及視力喪失病例的增加。預測期內的主要趨勢包括硬式高透氧隱形眼鏡的普及、光治療方法的進步、遺傳因素研究、數位平台和應用程式的普及以及阿托品眼藥水的研發。

近視治療包括旨在治療或控制近視（俗稱近視）的醫療或矯正方法。這種屈光不正會導致遠處物體模糊，而近處物體清晰。近視治療的主要目標是透過矯正屈光不正來改善視力和生活品質。它還致力於減緩近視的發展，從而減少對矯正鏡片的長期依賴，並實現更好的視覺健康。

近視的主要治療類別為單純性近視、高度近視和病理性近視。單純性近視是由於眼球過長或角膜過度彎曲引起的，導致遠距離視力模糊，可以透過矯正鏡片或屈光矯正手術治療。治療方法包括框架眼鏡、隱形眼鏡、屈光矯正手術、雷射輔助切除術(LASIK)、屈光切除術(PRK) 和角膜塑形術 (Ortho-K)。這些治療透過各種方式進行，包括口服和非口服。分銷管道包括直銷和零售，面向醫院、臨床實驗室、診所和參考實驗室等最終用戶。

2025 年春季美國突然提高關稅以及由此引發的貿易摩擦對醫療保健產業產生了重大影響，尤其是基本醫療設備、診斷設備和藥品的供應。醫院和醫療保健提供者正努力應對進口手術器械、診斷影像系統以及注射器和導管等消耗品成本的上漲，其中許多產品的國內替代品有限。這些不斷上漲的成本使醫療保健預算捉襟見肘，導致一些醫療機構推遲設備升級或將增加的費用轉嫁給患者。此外，原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產，造成供應鏈延遲。作為應對措施，該行業正在採用多樣化的籌資策略，盡可能擴大本地生產，並遊說對關鍵醫療產品免關稅。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供近視治療市場統計數據，例如全球市場規模、區域佔有率、近視治療市場佔有率的競爭對手、近視治療市場細分、市場趨勢以及近視治療行業的商機。本近視治療市場研究報告對產業現狀和未來趨勢進行了詳細分析，為您提供所需的全方位觀點。

未來五年9.3%的成長預測比我們先前的預測略有下降0.2個百分點。這一下降主要源自於美國與其他國家之間關稅的影響。貿易摩擦可能會擾亂美國的兒童眼科護理，因為這會增加新加坡和法國研發的阿托品眼藥水和近視預防眼鏡的成本，加速視力喪失，並增加長期眼科護理成本。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，貿易摩擦的影響可能會更加廣泛。

預計螢幕時間的增加將推動近視治療市場的成長。螢幕時間是指個人使用配備螢幕的裝置（例如智慧型手機、平板電腦、電腦和電視）的時間。推動這一成長的因素包括串流媒體服務、社群媒體平台、遠距工作和虛擬會議的日益普及。近視治療有助於緩解長時間螢幕時間引起的眼睛疲勞和不適，並提高視覺清晰度、焦點和整體舒適度。例如，美國疾病管制與預防中心 (CDC) 2024 年 10 月的數據顯示，在 2021 年 7 月至 2023 年 12 月期間，50.4% 的 12 至 17 歲青少年報告每天在螢幕上花費 4 小時或更長時間。此外，22.8% 的人每天在螢幕上花費 3 小時，17.8% 的人花費 2 小時，6.1% 的人花費 1 小時，3.0% 的人花費不到 1 小時。這些螢幕時間趨勢是推動近視治療市場擴張的關鍵因素。

近視治療市場的主要企業正致力於開發創新產品，例如光學生物計，以提高診斷準確性並提供個人化治療。光學生物計使用光來評估眼部參數，例如軸長和角膜曲率，有助於診斷和監測眼科疾病。例如，2023 年 2 月，日本眼科產品專家 Nidec Corporation 推出了 AL-Scan M 和 MV-1 儀器。 AL-Scan M 具有 3D 自動追蹤和自動拍攝功能，可實現與自動驗光儀類似的高效且使用者友好的測量。這些增強功能提高了患者的吞吐量，特別是對於年輕患者。 AL-Scan M 旨在精確測量軸長，這對於追蹤近視進展至關重要。此外，它與 MV-1 Myopia Viewer 軟體無縫整合，便於追蹤治療歷史和患者行為。

2023年1月，美國軟式隱形眼鏡製造商CooperVision收購了SynergEyes, Inc.，收購金額未揭露。此次收購旨在增強CooperVision的專業隱形眼鏡產品組合，並鞏固其在高階眼科護理市場的地位。 SynergEyes, Inc.總部位於美國，專門生產旨在應對近視加深的隱形眼鏡。

近視治療市場由提供近視預防計劃、視力治療以及生活方式和行為指導等服務的營業單位所賺取的收益構成。市場價值還包括服務提供者銷售或包含在其服務產品中的相關產品的價值。近視治療市場包括處方眼鏡、阿托品眼藥水和近視控制眼鏡的銷售。該市場的價值是指“出廠價”，即商品製造商或創造者銷售的商​​品價值，無論是出售給其他營業單位（包括下游製造商、經銷商和零售商）或直接出售給最終客戶。該市場中的商品價值還包括商品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球近視治療：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球近視治療市場：成長率分析
  • 全球近視治療市場表現：規模與成長，2019-2024
  • 全球近視治療市場預測：2024-2029年、2034年規模與成長
  • 全球近視治療：總潛在市場（TAM）

第6章 市場細分

  • 全球近視治療市場類型、績效及預測（2019-2024、2024-2029、2034）
  • 單純性近視
  • 嚴重近視
  • 病理性近視
  • 全球近視治療市場：按治療、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 眼鏡
  • 隱形眼鏡
  • 屈光矯正手術
  • 雷射誘導眼內骨骼和屈光矯正手術（LASIK）
  • 屈光切除術（PRK）
  • 角膜塑形術（角膜塑形）
  • 全球近視治療市場（依給藥途徑）：2019-2024 年、2024-2029 年、2034 年表現與預測
  • 口服
  • 腸外
  • 其他給藥途徑
  • 全球近視治療市場（依通路）：2019-2024 年、2024-2029 年、2034 年業績及預測
  • 直接競標
  • 零售
  • 其他分銷管道
  • 全球近視治療市場（按最終用戶、業績和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院或臨床實驗室
  • 醫生診所
  • 參考實驗室
  • 其他最終用戶
  • 全球近視治療市場：依單純近視類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 輕度近視
  • 中度近視
  • 全球近視治療市場：依高度近視類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 嚴重近視
  • 高度近視
  • 全球近視治療市場：依病理性近視類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 退化性近視
  • 惡性近視

第7章 區域和國家分析

  • 全球近視治療市場：依地區、績效及預測，2019-2024年、2024-2029年、2034年
  • 全球近視治療市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 近視治療市場：競爭格局
  • 近視治療市場：公司簡介
    • Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Hoya Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Vision Care Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • CooperVision Inc.
  • Menicon Co. Ltd.
  • Topcon Healthcare Inc.
  • Essilor Ltd.
  • NIDEK CO. LTD.
  • SightGlass Vision Inc.
  • SCHWIND eye-tech-solutions GmbH
  • Visioneering Technologies Inc.
  • MEDMONT INTERNATIONAL PTY LTD.
  • Vyluma Inc.
  • Haag-Streit Holding AG
  • NovaSight Ltd.
  • Euclid Vision Corporation
  • Treehouse Eyes LLC
  • Sydnexis Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年近視治療市場：提供新機會的國家
  • 2029年近視治療市場：細分領域帶來新機會
  • 2029年近視治療市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r33822u

Myopia treatment involves medical or corrective methods designed to address or manage myopia, commonly known as nearsightedness. This refractive error causes distant objects to appear blurry while nearby objects remain clear. The primary aim of myopia treatment is to enhance vision and improve quality of life by correcting refractive errors. Additionally, it focuses on controlling the progression of myopia, thereby reducing long-term dependence on corrective lenses for better vision health.

The primary categories of myopia treated include simple myopia, high myopia, and pathological myopia. Simple myopia, caused by an elongated eyeball or an overly curved cornea, results in blurry distant vision and can be treated with corrective lenses or refractive surgery. Treatment options include eyeglasses, contact lenses, refractive surgery, laser-assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), and orthokeratology (Ortho-K). These treatments are administered through various methods, such as oral or parenteral routes, among others. Distribution channels include direct tender and retail sales, catering to end users such as hospitals, clinical laboratories, physician offices, and reference laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The myopia treatment market research report is one of a series of new reports from The Business Research Company that provides myopia treatment market statistics, including the myopia treatment industry global market size, regional shares, competitors with the myopia treatment market share, detailed myopia treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the myopia treatment industry. This myopia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The myopia treatment market size has grown strongly in recent years. It will grow from $17.82 billion in 2024 to $19.52 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to an increase in the geriatric population, increasing government awareness programs, increasing awareness of myopia treatment, increasing investment in research and development, and rising incidence of distance vision impairment.

The myopia treatment market size is expected to see strong growth in the next few years. It will grow to $27.9 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to the increasing occurrence of distance vision impairment, increasing use of digital channels, rising healthcare infrastructure, rising incidence of myopia, and increasing cases of vision loss. Major trends in the forecast period include the adoption of rigid gas-permeable contact lenses, advancement in light-based therapies, cutting-edge research investigating the genetic factors, the adoption of digital platforms and apps, and development in atropine eye drops.

The forecast of 9.3% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. pediatric ophthalmology by inflating prices of atropine eye drops and myopia control spectacles developed in Singapore and France, resulting in progressive vision deterioration and higher long-term eye care expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the myopia treatment market is anticipated to be driven by the rising levels of screen time. Screen time refers to the duration individuals spend using devices equipped with screens, such as smartphones, tablets, computers, and televisions. Factors contributing to this increase include the growing popularity of streaming services, social media platforms, remote work, and virtual meetings. Myopia treatments are beneficial in mitigating eye strain and discomfort caused by extended screen use, enhancing visual clarity, focus, and overall comfort. For example, in October 2024, data from the Centers for Disease Control and Prevention (CDC), a US-based government agency, revealed that between July 2021 and December 2023, 50.4% of teenagers aged 12-17 reported spending four or more hours daily on screens. Additionally, 22.8% spent three hours, 17.8% spent two hours, 6.1% spent one hour, and 3.0% spent less than one hour per day on screens. This growing screen time trend is a significant factor fueling the expansion of the myopia treatment market.

Leading companies in the myopia treatment market are concentrating on developing innovative products, such as optical biometers, to improve diagnostic accuracy and provide personalized treatments. Optical biometers utilize light to assess eye parameters such as axial length and corneal curvature, aiding in the diagnosis and monitoring of eye conditions. For example, in February 2023, NIDEK Co., Ltd., a Japanese company specializing in ophthalmic products, introduced the AL-Scan M and MV-1 devices. The AL-Scan M features 3D auto-tracking and auto-shot capabilities, allowing for efficient and user-friendly measurements similar to those of an autorefractor. These enhancements boost patient throughput, especially for younger patients. The AL-Scan M is designed for precise axial length measurements, which are vital for tracking myopia progression. Additionally, it integrates smoothly with the MV-1 Myopia Viewer software, facilitating the tracking of treatment history and patient behavior.

In January 2023, CooperVision, Inc., a US-based producer of soft contact lenses, acquired SynergEyes, Inc. for an undisclosed sum. This acquisition is intended to bolster CooperVision's specialty contact lens portfolio and reinforce its standing in the advanced ocular care market. SynergEyes, Inc., also based in the US, specializes in manufacturing contact lenses designed to address myopia progression.

Major players in the myopia treatment market are Regeneron Pharmaceuticals Inc., Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Johnson & Johnson Vision Care Inc., CooperVision Inc., Menicon Co. Ltd., Topcon Healthcare Inc., Essilor Ltd., NIDEK CO. LTD., SightGlass Vision Inc., SCHWIND eye-tech-solutions GmbH, Visioneering Technologies Inc., MEDMONT INTERNATIONAL PTY LTD., Vyluma Inc., Haag-Streit Holding AG, NovaSight Ltd., Euclid Vision Corporation, Treehouse Eyes LLC, Sydnexis Inc., Neurobit Technologies Co. Ltd., Kubota Pharmaceutical Holdings Co. Ltd.

Asia Pacific was the largest region in the myopia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in myopia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the myopia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The myopia treatment market consists of revenues earned by entities by providing services such as myopia control programs, vision therapy, and lifestyle and behavioral guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. The myopia treatment market includes sales of prescription glasses, atropine drops, and myopia control glasses. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Myopia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on myopia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for myopia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The myopia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Simple Myopia; High Myopia; Pathological Myopia
  • 2) By Treatment: Eyeglasses; Contact Lenses; Refractive Surgery; Laser-Assisted In Situ Keratomileusis (LASIK); Photorefractive Keratectomy (PRK); Orthokeratology (Ortho-K)
  • 3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
  • 4) By Distribution Channel: Direct Tender; Retail Sales; Other Distribution Channels
  • 5) By End-User: Hospital Or Clinical Laboratories; Physician Offices; Reference Laboratories; Other End-Users
  • Subsegments:
  • 1) By Simple Myopia: Mild Myopia; Moderate Myopia
  • 2) By High Myopia: Severe Myopia; Very Severe Myopia
  • 3) By Pathological Myopia: Degenerative Myopia; Malignant Myopia
  • Companies Mentioned: Regeneron Pharmaceuticals Inc.; Alcon Inc.; Bausch Health Companies Inc.; Hoya Corporation; Johnson & Johnson Vision Care Inc.; CooperVision Inc.; Menicon Co. Ltd.; Topcon Healthcare Inc.; Essilor Ltd.; NIDEK CO. LTD.; SightGlass Vision Inc.; SCHWIND eye-tech-solutions GmbH; Visioneering Technologies Inc.; MEDMONT INTERNATIONAL PTY LTD.; Vyluma Inc.; Haag-Streit Holding AG; NovaSight Ltd.; Euclid Vision Corporation; Treehouse Eyes LLC; Sydnexis Inc.; Neurobit Technologies Co. Ltd.; Kubota Pharmaceutical Holdings Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Myopia Treatment Market Characteristics

3. Myopia Treatment Market Trends And Strategies

4. Myopia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Myopia Treatment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Myopia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Myopia Treatment Market Growth Rate Analysis
  • 5.4. Global Myopia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Myopia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Myopia Treatment Total Addressable Market (TAM)

6. Myopia Treatment Market Segmentation

  • 6.1. Global Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Simple Myopia
  • High Myopia
  • Pathological Myopia
  • 6.2. Global Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Eyeglasses
  • Contact Lenses
  • Refractive Surgery
  • Laser-Assisted In Situ Keratomileusis (LASIK)
  • Photorefractive Keratectomy (PRK)
  • Orthokeratology (Ortho-K)
  • 6.3. Global Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Parenteral
  • Other Routes Of Administration
  • 6.4. Global Myopia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Tender
  • Retail Sales
  • Other Distribution Channels
  • 6.5. Global Myopia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Or Clinical Laboratories
  • Physician Offices
  • Reference Laboratories
  • Other End-Users
  • 6.6. Global Myopia Treatment Market, Sub-Segmentation Of Simple Myopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mild Myopia
  • Moderate Myopia
  • 6.7. Global Myopia Treatment Market, Sub-Segmentation Of High Myopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Severe Myopia
  • Very Severe Myopia
  • 6.8. Global Myopia Treatment Market, Sub-Segmentation Of Pathological Myopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Degenerative Myopia
  • Malignant Myopia

7. Myopia Treatment Market Regional And Country Analysis

  • 7.1. Global Myopia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Myopia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Myopia Treatment Market

  • 8.1. Asia-Pacific Myopia Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Myopia Treatment Market

  • 9.1. China Myopia Treatment Market Overview
  • 9.2. China Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Myopia Treatment Market

  • 10.1. India Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Myopia Treatment Market

  • 11.1. Japan Myopia Treatment Market Overview
  • 11.2. Japan Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Myopia Treatment Market

  • 12.1. Australia Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Myopia Treatment Market

  • 13.1. Indonesia Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Myopia Treatment Market

  • 14.1. South Korea Myopia Treatment Market Overview
  • 14.2. South Korea Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Myopia Treatment Market

  • 15.1. Western Europe Myopia Treatment Market Overview
  • 15.2. Western Europe Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Myopia Treatment Market

  • 16.1. UK Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Myopia Treatment Market

  • 17.1. Germany Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Myopia Treatment Market

  • 18.1. France Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Myopia Treatment Market

  • 19.1. Italy Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Myopia Treatment Market

  • 20.1. Spain Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Myopia Treatment Market

  • 21.1. Eastern Europe Myopia Treatment Market Overview
  • 21.2. Eastern Europe Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Myopia Treatment Market

  • 22.1. Russia Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Myopia Treatment Market

  • 23.1. North America Myopia Treatment Market Overview
  • 23.2. North America Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Myopia Treatment Market

  • 24.1. USA Myopia Treatment Market Overview
  • 24.2. USA Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Myopia Treatment Market

  • 25.1. Canada Myopia Treatment Market Overview
  • 25.2. Canada Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Myopia Treatment Market

  • 26.1. South America Myopia Treatment Market Overview
  • 26.2. South America Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Myopia Treatment Market

  • 27.1. Brazil Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Myopia Treatment Market

  • 28.1. Middle East Myopia Treatment Market Overview
  • 28.2. Middle East Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Myopia Treatment Market

  • 29.1. Africa Myopia Treatment Market Overview
  • 29.2. Africa Myopia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Myopia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Myopia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Myopia Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Myopia Treatment Market Competitive Landscape
  • 30.2. Myopia Treatment Market Company Profiles
    • 30.2.1. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Hoya Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Johnson & Johnson Vision Care Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Myopia Treatment Market Other Major And Innovative Companies

  • 31.1. CooperVision Inc.
  • 31.2. Menicon Co. Ltd.
  • 31.3. Topcon Healthcare Inc.
  • 31.4. Essilor Ltd.
  • 31.5. NIDEK CO. LTD.
  • 31.6. SightGlass Vision Inc.
  • 31.7. SCHWIND eye-tech-solutions GmbH
  • 31.8. Visioneering Technologies Inc.
  • 31.9. MEDMONT INTERNATIONAL PTY LTD.
  • 31.10. Vyluma Inc.
  • 31.11. Haag-Streit Holding AG
  • 31.12. NovaSight Ltd.
  • 31.13. Euclid Vision Corporation
  • 31.14. Treehouse Eyes LLC
  • 31.15. Sydnexis Inc.

32. Global Myopia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Myopia Treatment Market

34. Recent Developments In The Myopia Treatment Market

35. Myopia Treatment Market High Potential Countries, Segments and Strategies

  • 35.1 Myopia Treatment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Myopia Treatment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Myopia Treatment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer